Kanbi  Pharma  Teknoloji  Limite
943516-54-9 6,6-dimethyl-3-azabicyclo-[3.1.0]hexane
943516-54-9 6,6-dimethyl-3-azabicyclo-[3.1.0]hexane

{{0}}{{1{1}dimethyl-3-azabicyclo-[3.1.0]hexane

CAS943516-54-9
MF:C7H13N
MW:111.18
EINECS:1308068-626-2
MDL Tèb:MFCD13176114

Voye rechèch
Dekri teren

Pwopriyete
Pwen bouyi: 135 degre
Dansite 0.911
Flash pwen: 24 degre
pka11.51±{2{2}.40
 

Aplikasyon:

Itilizasyon prensipal la nan DMADCN se kòm yon reyaktif nan sentèz òganik. Akòz estrikti inik li yo ak reyaksyon, DMADCN gen anpil aplikasyon nan sentèz òganik.

 

Sinonim:

6,6-DIMETHYL-3-AZABICYCLO[3.1.0]HEXANE

943516-54-9

MFCD13176114

Paxlovid Entèmedyè

6,6-DiMethyl-3-azabicyclo[3.1.{5{5}]hexane Boceprevir Key interMediate

6,6-diMethyl-3-azabicyclo[3.1.0]hexane (Kloridrat)

6,6-dimethyl-3-azabicyclo-[3.1.0]hexane

 

Baj popilè: {{0}},6-dimethyl-3-azabicyclo-[3.1.0]hexane, Lachin 943516-54-9 6,6-dimethyl{{9 }}azabicyclo-[3.1.0]hexane manifakti yo, founisè

Inquiry
goTop

(0/10)

clearall